153 related articles for article (PubMed ID: 31490711)
21. New epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
Tsuboi H; Matsumoto I; Wakamatsu E; Nakamura Y; Iizuka M; Hayashi T; Goto D; Ito S; Sumida T
Clin Exp Immunol; 2010 Oct; 162(1):53-61. PubMed ID: 20731676
[TBL] [Abstract][Full Text] [Related]
22. A crucial role of RORγt in the development of spontaneous Sialadenitis-like Sjögren's syndrome.
Iizuka M; Tsuboi H; Matsuo N; Asashima H; Hirota T; Kondo Y; Iwakura Y; Takahashi S; Matsumoto I; Sumida T
J Immunol; 2015 Jan; 194(1):56-67. PubMed ID: 25411202
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies against the Second Extracellular Loop of M3R Do neither Induce nor Indicate Primary Sjögren's Syndrome.
Chen Y; Zheng J; Huang Q; Deng F; Huang R; Zhao W; Yin J; Song L; Chen J; Gao X; Liu Z; Petersen F; Yu X
PLoS One; 2016; 11(2):e0149485. PubMed ID: 26901532
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies against muscarinic acetylcholine receptor M
Yu X; Riemekasten G; Petersen F
Front Biosci (Landmark Ed); 2018 Jun; 23(11):2053-2064. PubMed ID: 29772545
[TBL] [Abstract][Full Text] [Related]
25. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R.
Schegg V; Vogel M; Didichenko S; Stadler MB; Beleznay Z; Gadola S; Sengupta C; Stadler BM; Miescher SM
Biologicals; 2008 Jul; 36(4):213-22. PubMed ID: 18249005
[TBL] [Abstract][Full Text] [Related]
26. Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor.
Tsuboi H; Nakamura Y; Iizuka M; Matsuo N; Matsumoto I; Sumida T
Mod Rheumatol; 2012 Apr; 22(2):264-71. PubMed ID: 21877253
[TBL] [Abstract][Full Text] [Related]
27. Mimotope mimicking epidermal growth factor receptor alleviates mononuclear cell infiltration in exocrine glands induced by muscarinic acetylcholine 3 receptor.
Yang L; Wang Y; Xing R; Bai L; Li C; Li Z; Liu X
Clin Immunol; 2016 Feb; 163():111-9. PubMed ID: 26794912
[TBL] [Abstract][Full Text] [Related]
28. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome.
Sumida T; Tsuboi H; Iizuka M; Asashima H; Matsumoto I
Mod Rheumatol; 2013 Sep; 23(5):841-5. PubMed ID: 23135882
[TBL] [Abstract][Full Text] [Related]
29. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
[TBL] [Abstract][Full Text] [Related]
30. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay.
Gao J; Cha S; Jonsson R; Opalko J; Peck AB
Arthritis Rheum; 2004 Aug; 50(8):2615-21. PubMed ID: 15334476
[TBL] [Abstract][Full Text] [Related]
31. Younger patients with primary Sjögren's syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies.
Jayakanthan K; Ramya J; Mandal SK; Sandhya P; Gowri M; Danda D
Clin Rheumatol; 2016 Mar; 35(3):657-62. PubMed ID: 26809799
[TBL] [Abstract][Full Text] [Related]
32. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
33. Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen.
Iizuka M; Wakasa Y; Tsuboi H; Asashima H; Hirota T; Kondo Y; Matsumoto I; Takaiwa F; Sumida T
Plant Biotechnol J; 2014 Oct; 12(8):1143-52. PubMed ID: 24989432
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
Hayashi Y; Haneji N; Hamano H
Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145
[TBL] [Abstract][Full Text] [Related]
35. Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome.
Naito Y; Matsumoto I; Wakamatsu E; Goto D; Ito S; Tsutsumi A; Sumida T
Ann Rheum Dis; 2006 Feb; 65(2):269-71. PubMed ID: 16410534
[No Abstract] [Full Text] [Related]
36. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
Jin M; Hwang SM; Davies AJ; Shin Y; Bae JS; Lee JH; Lee EB; Song YW; Park K
Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
[TBL] [Abstract][Full Text] [Related]
37. Muscarinic type 3 receptor induces cytoprotective signaling in salivary gland cells through epidermal growth factor receptor transactivation.
Kajiya M; Ichimonji I; Min C; Zhu T; Jin JO; Yu Q; Almazrooa SA; Cha S; Kawai T
Mol Pharmacol; 2012 Jul; 82(1):115-24. PubMed ID: 22511543
[TBL] [Abstract][Full Text] [Related]
38. Novel fragments of the Sjögren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death.
Nagaraju K; Cox A; Casciola-Rosen L; Rosen A
Arthritis Rheum; 2001 Oct; 44(10):2376-86. PubMed ID: 11665980
[TBL] [Abstract][Full Text] [Related]
39. Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndrome.
Zuo J; Williams AE; Park YJ; Choi K; Chan AL; Reeves WH; Bubb MR; Lee YJ; Park K; Stewart CM; Cha S
J Immunol Methods; 2016 Oct; 437():28-36. PubMed ID: 27460476
[TBL] [Abstract][Full Text] [Related]
40. A novel cell-based assay for inhibitory anti-muscarinic type 3 receptor antibodies in primary Sjögren's syndrome.
Bastian I; Gordon TP; Jackson MW
J Immunol Methods; 2015 Dec; 427():117-21. PubMed ID: 26584897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
